| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |